Using procedure of emulsification-lyophilization to form lipid A-incorporating cochleates as an effective oral mucosal vaccine adjuvant-delivery system (VADS)

International Journal of Pharmaceutics

Volumn 468, Issue 1-2, 2014, Pages 39-49

  Wang, Ning ^a   Wang, Ting ^b,c   Zhang, Meiling ^b   Chen, Ruonan ^b   Deng, Yihui ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

^c JINING MEDICAL UNIVERSITY   (China)

Author keywords

Cochleate; Immune response; Lyophilization; Mucosa associated lymphoid tissue; Pathogen associated molecular pattern; Vaccine adjuvant delivery system

Indexed keywords

BOVINE SERUM ALBUMIN; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; LIPID A COCHLEATE; PHOSPHORYL LIPID A; UNCLASSIFIED DRUG; DRUG CARRIER; EMULSION; EXCIPIENT; IMMUNOLOGICAL ADJUVANT; LIPID A; POWDER; SECRETORY IMMUNOGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; EMULSION; FEMALE; FREEZE DRYING; IMMUNE RESPONSE; INTESTINAL SECRETIONS; KUNMING MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ROOM TEMPERATURE; SPLEEN CELL; SUPERNATANT; VACCINE ADJUVANT DELIVERY SYSTEM; VAGINAL SECRETION; ANIMAL; BLOOD; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; DRUG STABILITY; HUMORAL IMMUNITY; IMMUNOLOGY; MEDICINAL CHEMISTRY; METABOLISM; MOUTH MUCOSA; MUCOSAL IMMUNITY; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PHAGOCYTOSIS; PHARMACEUTICS; POWDER; PROCEDURES; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG STABILITY; EMULSIONS; EXCIPIENTS; FEMALE; FREEZE DRYING; IMMUNITY, HUMORAL; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LIPID A; MICE; MOUTH MUCOSA; PARTICLE SIZE; PHAGOCYTOSIS; POWDERS; SERUM ALBUMIN, BOVINE; TECHNOLOGY, PHARMACEUTICAL; TH1 CELLS; TH2 CELLS;

EID: 84899440711     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.04.002     Document Type: Article

References (55)

1. R. Acevedo, O. Perez, C. Zayas, J.L. Perez, A. Callico, B. Cedre, L. Garcia, D. McKee, A.B. Mullen, and V.A. Ferro Cochleates derived from Vibrio cholerae O1 proteoliposomes: the impact of structure transformation on mucosal immunisation PLoS One 7 2012 e46461
2. M.J. Bevan Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay Journal of Experimental Medicine 143 1976 1283 1288
3. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Analytical Biochemistry 72 1976 248 254
4. J.D. Campo, C. Zayas, B. Romeu, R. Acevedo, E. Gonzalez, G. Bracho, M. Cuello, O. Cabrera, J. Balboa, and M. Lastre Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses Methods 49 2009 301 308
5. + T cell responses induced by a recombinant live malaria vaccine in mice PLoS One 6 2013 e22442
6. C.R. Casella, and T.C. Mitchell Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant Cellular and Molecular Life Sciences 65 2008 3231 3240
7. D. Chen, and D. Zehrung Desirable attributes of vaccines for deployment in low-resource settings Journal of Pharmaceutical Sciences 102 2012 29 33
8. J.D. Clark, R.L. Baldwin, K.A. Bayne, M.J. Brown, G.F. Gebhart, J.C. Gonder, J.K. Gwathmey, M.E. Keeling, D.F. Kohn, J.W. Robb, O.A. Smith, J.A.D. Steggerda, J.G. Vandenbergh, W.J. White, S. Williams-Blangero, and J.L. VandeBerg Guide for the Care and Use of Laboratory Animals 1996 National Academy Press Washington, D.C
9. C.W. Cutler, and R. Jotwani Dendritic cells at the oral mucosal interface Journal of Dental Research 85 2006 678 689 (Pubitemid 44297321)
10. M.A. Fishman, and A.S. Perelson Th1/Th2 differentiation and cross-regulation Bulletin of Mathematical Biology 61 1999 403 436 (Pubitemid 29274614)
11. C.H. Fiske, and Y. Subbarow The colorimetric determination of phosphorous Journal of Biological Chemistry 66 1925 375 400
12. A. Frey, B. Meckelein, D. Externest, and M.A. Schmidt A stable and highly sensitive 3,3′,5,5′-tetramethylbenzidine-based substrate reagent for enzyme-linked immunosorbent assays Journal of Immunological Methods 233 2000 47 56 (Pubitemid 30058234)
13. B. Frey, and U.S. Gaipl The immune functions of phosphatidylserine in membranes of dying cells and microvesicles Seminars in Immunopathology 33 2011 497 516
14. S. Ge, K. Kojio, A. Takahara, and T. Kajiyama Bovine serum albumin adsorption onto immobilized organotrichlorosilane surface: influence of the phase separation on protein adsorption patterns Journal of Biomaterials Science, Polymer Edition 9 1998 131 150 (Pubitemid 28058524)
15. A. Gebril, M. Alsaadi, R. Acevedo, A.B. Mullen, and V.A. Ferro Optimizing efficacy of mucosal vaccines Expert Review of Vaccines 11 2012 1139 1155
16. L.I. Giannola, F.M. Sutera, and V. De Caro Physical methods to promote drug delivery on mucosal tissues of the oral cavity Expert Opinion on Drug Delivery 10 2013 1449 1462
17. L. Guo, J. Chen, Y. Qiu, S. Zhang, B. Xu, and Y. Gao Enhanced transcutaneous immunization via dissolving microneedle array loaded with liposome encapsulated antigen and adjuvant International Journal of Pharmaceutics 447 2013 22 30
18. J. Holmgren, C. Czerkinsky, K. Eriksson, and A. Mharandi Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges Vaccine 21 2003 S89 S95
19. T. Ichihashi, T. Satoh, C. Sugimoto, and K. Kajino Emulsified phosphatidylserine, simple and effective peptide carrier for induction of potent epitope-specific T cell responses PLoS One 8 2013 e60068
20. K. Khatri, A.K. Goyal, P.N. Gupta, N. Mishra, A. Mehta, and S.P. Vyas Surface modified liposomes for nasal delivery of DNA vaccine Vaccine 26 2008 2225 2233
21. S.H. Kim, K.Y. Lee, and Y.S. Jang Mucosal immune system and M cell-targeting strategies for oral mucosal vaccination Immune Network 12 2012 165 175
22. M. Kovacsovics-Bankowski, K. Clark, B. Benacerraf, and K.L. Rock Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages Proceedings of the National Academy of Sciences of the United States of America 90 1993 4942 4946 (Pubitemid 23182951)
23. M.N. Kweon Sublingual mucosa: a new vaccination route for systemic and mucosal immunity Cytokine 54 2011 1 5
24. B.Y. Lee, B.E. Cakouros, T.M. Assi, D.L. Connor, J. Welling, S. Kone, A. Djibo, A.R. Wateska, L. Pierre, and S.T. Brown The impact of making vaccines thermostable in Niger's vaccine supply chain Vaccine 30 2012 5637 5643
25. M.M. Levine IDEAL vaccines for resource poor settings Vaccine 29 2011 D116 D125
26. N. Lycke Recent progress in mucosal vaccine development: potential and limitations Nature Reviews Immunology 12 2012 592 605
27. J.F. Mann, R. Acevedo, J.D. Campo, O. Perez, and V.A. Ferro Delivery systems: a vaccine strategy for overcoming mucosal tolerance? Expert Review of Vaccines 8 2009 103 112
28. V. Mata-Haro, C. Cekic, M. Martin, P.M. Chilton, C.R. Casella, and T.C. Mitchell The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4 Science 316 2007 1628 1632 (Pubitemid 46982038)
29. J. Mestecky, M.W. Russell, and C.O. Elson Perspectives on mucosal vaccines: is mucosal tolerance a barrier? The Journal of Immunology 179 2007 5633 5638
30. P.M. Moyle, R.P. McGeary, J.T. Blanchfield, and I. Toth Mucosal immunisation: adjuvants and delivery systems Current Drug Delivery 1 2004 385 396
31. P.M. Moyle, and I. Toth Modern subunit vaccines: development, components, and research opportunities ChemMedChem 8 2013 360 376
32. T. Nochi, H. Takagi, Y. Yuki, L. Yang, T. Masumura, M. Mejima, U. Nakanishi, A. Matsumura, A. Uozumi, T. Hiroi, S. Morita, K. Tanaka, F. Takaiwa, and H. Kiyono Rice-based mucosal vaccine as a global strategy for cold-chain-and needle-free vaccination Proceedings of the National Academy of Sciences of the United States of America 104 2007 10986 10991 (Pubitemid 47175213)
33. R.E. O'Hehir, A. Sandrini, G.P. Anderson, and J.M. Rolland Sublingual allergen immunotherapy: immunological mechanisms and prospects for refined vaccine preparation Current Medicinal Chemistry 14 2007 2235 2244 (Pubitemid 47570684)
34. S. Ozawa, A. Mirelman, M.L. Stack, D.G. Walker, and O.S. Levine Cost-effectiveness and economic benefits of vaccines in low-and middle-income countries: a systematic review Vaccine 31 2012 96 108
35. M. Pastor, A. Esquisabel, A. Talavera, G. Ano, S. Fernandez, B. Cedre, J.F. Infante, A. Callico, and J.L. Pedraz An approach to a cold chain free oral cholera vaccine: in vitro and in vivo characterization of Vibrio cholerae gastro-resistant microparticles International Journal of Pharmaceutics 448 2013 247 258
36. T.T. Pham, G. Barratt, J.P. Michel, P.M. Loiseau, and M. Saint-Pierre-Chazalet Interactions of antileishmanial drugs with monolayers of lipids used in the development of amphotericin B-miltefosine-loaded nanocochleates Colloids and Surfaces B: Biointerfaces 106 2013 224 233
37. S.A. Plotkin Vaccines: past, present and future Nature Medicine 11 2005 S5 S11
38. V.E. Schijns, and E.C. Lavelle Trends in vaccine adjuvants Expert Review of Vaccines 10 2011 539 550
39. I. Segarra, D.A. Movshin, and L. Zarif Pharmacokinetics and tissue distribution after intravenous administration of a single dose of amphotericin B cochleates, a new lipid-based delivery system Journal of Pharmaceutical Sciences 91 2002 1827 1837 (Pubitemid 34810528)
40. H. Shen, A.L. Ackerman, V. Cody, A. Giodini, E.R. Hinson, P. Cresswell, R.L. Edelson, W.M. Saltzman, and D.J. Hanlon Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles Immunology 117 2006 78 88
41. W.F. Tonnis, A.J. Lexmond, H.W. Frijlink, A.H. de Boer, and W. Hinrichs Devices and formulations for pulmonary vaccination Expert Opinion on Drug Delivery 10 2013 1383 1397
42. J.M. Vyas, A.G. Van der Veen, and H.L. Ploegh The known unknowns of antigen processing and presentation Nature Reviews Immunology 8 2008 607 618
43. L. Wang, and R.L. Coppel Oral vaccine delivery: can it protect against non-mucosal pathogens? Expert Review of Vaccines 7 2008 729 738
44. S.H. Wang, S.M. Kirwan, S.N. Abraham, H.F. Staats, and A.J. Hickey Stable dry powder formulation for nasal delivery of anthrax vaccine Journal of Pharmaceutical Sciences 101 2012 31 47
45. S.H. Wang, A.L. Thompson, A.J. Hickey, and H.F. Staats Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery Current Topics in Microbiology and Immunology 354 2012 121 156
46. T. Wang, Y. Deng, Y. Geng, Z. Gao, J. Zou, and Z. Wang Preparation of submicron unilamellar liposomes by freeze-drying double emulsions Biochimica et Biophysica Acta 1758 2006 222 231 (Pubitemid 44294663)
47. T. Wang, N. Wang, X. Jin, K. Zhang, and T. Li A novel procedure for preparation of submicron liposomes-lyophilization of oil-in-water emulsions Journal of Liposome Research 19 2009 231 240
48. T. Wang, N. Wang, H. Song, X. Xi, J. Wang, A. Hao, and T. Li Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine European Journal of Pharmaceutical Sciences 44 2011 127 135
49. T. Wang, N. Wang, W. Sun, and T. Li Preparation of submicron liposomes exhibiting efficient entrapment of drugs by freeze-drying water-in-oil emulsions Chemistry and Physics of Lipids 164 2011 151 157
50. S. Yotsumoto, T. Kakiuchi, and Y. Aramaki Enhancement of IFN-gamma production for Th1-cell therapy using negatively charged liposomes containing phosphatidylserine Vaccine 25 2007 5256 5262 (Pubitemid 46977545)
51. Y. Yuki, and H. Kiyono Mucosal vaccines: novel advances in technology and delivery Expert Review of Vaccines 8 2009 1083 1097
52. M. Zaman, S. Chandrudu, and I. Toth Strategies for intranasal delivery of vaccines Drug Delivery and Translational Research 3 2013 100 109
53. L. Zarif Elongated supramolecular assemblies in drug delivery Journal of Controlled Release 81 2002 7 23 (Pubitemid 34460570)
54. L. Zarif Drug delivery by lipid cochleates Methods in Enzymology 391 2005 314 329 (Pubitemid 40254043)
55. C. Zayas, D. Gonzalez, R. Acevedo, J. del Campo, M. Lastre, E. Gonzalez, B. Romeu, M. Cuello, J. Balboa, O. Cabrera, L. Guilherme, and O. Perez Pilot scale production of the vaccine adjuvant proteoliposome derived cochleates (AFCo1) from Neisseria meningitidis serogroup B BMC Immunol 14 2013 S4